Alpha DNA Investment Management’s Royal Caribbean RCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,616
Closed -$895K 246
2024
Q2
$895K Sell
5,616
-1,015
-15% -$146K 0.35% 63
2024
Q1
$922K Buy
+6,631
New +$828K 0.34% 60

Other funds holding RCL

Alpha DNA Investment Management's RCL Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Royal Caribbean (RCL) in Q3 2024, closing a stake of 5,616 shares — an estimated $895K sold.

Alpha DNA Investment Management first reported a position in RCL in Q1 2024 and held it in 2 quarters. The position peaked at $922K in Q1 2024. 948 funds tracked by Wall St. Rank hold RCL as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Royal Caribbean position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,616 Royal Caribbean shares in Q3 2024, an estimated $895K.
  • Alpha DNA Investment Management first reported a position in Royal Caribbean in Q1 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's Royal Caribbean position peaked at $922K in Q1 2024.
  • 948 funds tracked by Wall St. Rank held Royal Caribbean as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.